A Phase 1 Study to Evaluate the Relative Bioavailability of a VX-828 Tablet Formulation

Clinical trial NCT06861413 · COMPLETED

Trial details

NCT number: NCT06861413
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2025-04-01
Primary completion: 2025-05-05
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.